Refine
Document Type
- Doctoral Thesis (4)
Language
- English (4) (remove)
Has Fulltext
- yes (4)
Is part of the Bibliography
- no (4)
Keywords
Institute
- Biowissenschaften (3)
- Medizin (1)
The role of peroxisome proliferator-activated receptor gamma during sepsis-induced lymphopenia
(2011)
Sepsis is one of the most common diseases on intensive care units all over the world and accounts there for the highest mortality rate. One of the hallmarks of sepsis is an accelerated T-cell apoptosis, resulting in a compromised immune state with the inability to eradicate pathogens. This promotes organ damage or even organ failure. A multiple organ dysfunction evolves, which often ends up in septic shock and death. Recently, it was shown that severe T-cell depletion correlates with sepsis mortality. When inhibiting T-cell apoptosis, an increased mouse survival was observed in experimental sepsis. ...
The capacity of pathogenic bacteria to adhere to host cells and to avoid subsequent clearance by the host´s immune response is the initial and most decisive step leading to infections. Human pathogenic bacteria circulating in the bloodstream need to find ways to interact with endothelial cells (ECs) lining the blood vessels to infect and colonise the host. The extracellular matrix (ECM) of ECs might represent an attractive initial target for bacterial interaction, as many bacterial adhesins have reported affinities to ECM proteins, particularly fibronectin (Fn). Trimeric autotransporter adhesins (TAA) have been described as important pathogenicity factors of Gram-negative bacteria. The TAA from human pathogenic Bartonella henselae, Bartonella adhesin A (BadA), is one of the longest and best characterised adhesin and represents a prototypic TAA due to its domain architecture. B. henselae, the causative agent of cat scratch disease, endocarditis, and bacillary angiomatosis, adheres to ECs and ECM proteins via BadA interaction.
In this research, it was determined that the interaction between BadA and Fn is essential for B. henselae host cell adhesion. BadA interactions were identified within the heparin-binding domains of Fn, and the exact binding sites were revealed by mass spectrometry analysis of chemically crosslinked whole-cell bacteria and Fn. It turned out that specific BadA interactions with defined Fn regions represent the molecular basis for bacterial adhesion to ECs. These data were confirmed by using BadA-deficient bacteria and CRISPR-Cas FN1 knockout ECs. It was also identified that BadA binds to Fn from both cellular and plasma origin, suggesting that B. henselae binding to Fn might possibly take part in other infection processes apart from bacterial adherence, e.g. evasion from the host cell immune system.
Interactions between TAAs and Fn represent a key step for adherence of B. henselae to ECs. Still, Fn-mediated binding is of more significant importance for pathogenic bacteria than broadly recognised. Fn removal from the ECM environment of ECs, also reduced adherence of Staphylococcus aureus, Borrelia burgdorferi, and Acinetobacter baumannii to host cells Interactions between adhesins and Fn might therefore represent a crucial step for the adhesion of human-pathogenic Gram-negative and Gram-positive bacteria targeting the ECs as a niche of infection or as means for persistence.
This research demonstrated that combining large-scale analysis approaches to describe protein-protein interactions with supportive functional readouts (binding assays) allows for the discrimination of crucial interactions involved in bacterial adhesion to the host. The herein-described experimental approaches and tools might guide future research for other pathogenic bacteria and represent an initial point for the future generation of anti-virulence strategies to inhibit bacterial binding to host cells.
Vascular tumors associated with chronic B. henselae infections are unique examples of infection-associated pathological angiogenesis. The chaotic vascular architecture and prominent myeloid infiltrate of B. henselae induced vascular lesions show many similarities with malignant tumors.
In human cancers infiltrating myeloid cells play a decisive role in tumor progression and vascularization. In particular, tumor associated macrophages (TAMs) transform the tumor microenvironment, drive tumor invasion and vascularization through secretion of pro-angiogenic and immune modulatory cytokines and participation in matrix remodeling processes.
Myeloid angiogenic cells (MACs) are a subset of circulating myeloid progenitors with important roles in regenerative and pathological angiogenesis and a critical involvement in tumor vascularization. The phenotypic plasticity and importance of MACs in pathological angiogenic processes, position these cells as key potential players in B. henselae associated vascular tumor formation.
To investigate the possible role of MACs in B henselae induced pathological angiogenesis, the objective of this study was to examine the interaction of B. henselae with MACs and determine how this may affect their angiogenic capacity.
Building on previous work by Mӓndle (2005) this study has demonstrated that MACs are susceptible to infection with B. henselae and reside in intracellular vacuoles. As in endothelial cells, infection of MACs with B. henselae was associated with inhibition of apoptosis and activation of endogenous angiogenic programs including activation of the angiogenic transcription factor HIF-1.
In addition to angiogenic re-programming on a molecular level B. henselae infection increases MAC functional angiogenic capacity. B. henselae infected MACs were found to integrate into growing endothelium and increase the rate of angiogenic sprouting in a paracrine manner.
When cultured in a Matrigel capillary formation assay, infected MACs were also found to form networks of capillary-like structures that were stable over long periods of time. The B. henselae pathogenicity factor BadA was essential for the induction of this vascular mimicry phenotype as well as the activation of HIF-1 in infected MACs indicating that this factor may play an important role in MAC angiogenic re-programming.
Examination of infected MACs via FACS analysis, cytospin immunohistochemistry and qRT-PCR revealed that endothelial differentiation does not play a role in the B. henselae induced pro-angiogenic phenotype. Instead, MACs were shown to be myeloid in phenotype displaying typical macrophage markers which were upregulated upon B. henselae infection and maintained over long-term culture.
The increased angiogenic activity of B. henselae infected MACs was found to be associated with a broad phenotypic reprogramming in infected cells. In particular, gene expression programs related to angiogenesis, structural organization, apoptosis, sterol metabolism and immune regulation, were upregulated. Further examination of microarray gene expression profiles revealed that B. henselae infected MACs display a predominantly M2 anti-inflammatory macrophage activation status.
Finally, examination of the paracrine microenvironment created by B. henselae infected MACs revealed a diverse cytokine secretion profile dominated by inflammatory-angiogenic cytokines and matrix remodeling elements and lacking expression of some of the most important cytokines involved in the expansion of the inflammatory response. This B. henselae induced activation status was demonstrated to be distinct from the general inflammatory response induced by E. coli LPS treatment.
Comparison of B. henselae infected MACs to TAMs revealed many parallels in functional and phenotypic characteristics. Both TAMs and B. henselae infected MACs demonstrate increased angiogenic capacity, invasive, and immune modulatory phenotypes and the ability to participate in the formation of vascular mimicry phenotypes under angiogenic pressure. Furthermore, the pro-angiogenic paracrine microenvironment created by B. henselae infected MACs shows many similarities to the TAM-created tumor-microenvironment.
In conclusion, these investigations have demonstrated that the infection of MACs with B. henselae results in the phenotypic re-programming towards TAM-like cells with increased pro-angiogenic, invasive and immune-modulatory qualities. The results of this study elucidate new aspects of B. henselae pathogenicity in myeloid cells and highlight the role of these cells as paracrine mediators of B. henselae induced vascular tumor formation. In addition, these findings demonstrate that manipulation of myeloid cells by pathogenic bacteria can contribute to microenvironmental regulation of pathological tissue growth and suggest parallels underlying bacterial infections and cancer.
Adhesion to host cells is the first and most crucial step in infections with pathogenic Gram negative bacteria and is often mediated by trimeric autotransporter adhesins (TAAs). TAA-producing bacteria are the causative agent of many human diseases and TAA targeted anti-adhesive compounds might counteract such bacterial infections. The modularly structured Bartonella adhesin A (BadA) is one of the best characterised TAAs and serves as an attractive adhesin to study the domain-function relationship of TAAs during infection. BadA is a major virulence factor of B. henselae and is essential for the initial attachment to host cells via adhesion to extracellular matrix proteins. B. henselae is the causative agent of cat scratch disease and adheres to fibronectin using its long BadA fibres. The life cycle of this pathogen, with alternating host conditions, drives evolutionary and host-specific adaptations.
Human, feline, and laboratory adapted B. henselae isolates display genomic and phenotypic differences. By analysing the genomes of eight B. henselae strains using long-read sequencing, a variable genomic badA island with a diversified and highly repetitive badA gene flanked by badA pseudogenes was identified. Moreover, numerous conserved flanking genes were characterised, however, their influence on the regulation of badA expression and modification remains to be explored. It seems that B. henselae G 5436 is the evolutionary ancestor of the other B. henselae strains analysed in this work. The diversity of the badA island among the B. henselae strains indicates that the downstream badA-like domain region might be used as a ‘toolbox’ for rearrangements in the badA gene. Overall, it is suggested that badA-domain duplications, insertions, and/or deletions are the result of active phase variation via site-specific recombination and contribute to rapid host adaptation in the scope of pathogenicity, immune evasion, and/or enhanced long-term colonisation.
The model strain B. henselae Marseille expresses a badA gene that includes 30 repetitive neck/stalk domains, each consisting of several predicted structural motifs. To further elucidate the motif sequences that mediate fibronectin binding, various modified badA constructs were generated. Their ability to bind fibronectin was assessed via whole-cell ELISA and fluorescence microscopy. In conclusion, it is suggested that BadA adheres to fibronectin in a cumulative fashion with quick saturation via unpaired β-strands appearing in structural motifs present in BadA neck/stalk domains 19, 27, and other homologous domains. Furthermore, antibodies targeting a 15-mer amino acid sequence in the DALL motif of BadA neck/stalk domain 27 were able to reduce fibronectin binding of the B. henselae mutant strain S27. Moreover, this DALL motif sequence is conserved in the genome of all analysed B. henselae strains. The identification of common binding motifs between BadA and fibronectin supports the development of new anti-adhesive compounds that might inhibit the initial adherence of B. henselae and other TAA-producing pathogens during infection.